Table 1 Background characteristics of the study population
From: The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
Variable | N = 109 | Group | P value | |
|---|---|---|---|---|
Suboptimal cytoreduction | Optimal cytoreduction | |||
N = 56 | N = 53 | |||
Age (years) | 0.269 | |||
Mean ± Std | 47.48 ± 11.347 | 48.66 ± 9.648 | 46.24 ± 12.880 | |
Median | 47.00 | 47.00 | 47.00 | |
Range (min–max) | 17/00–75.00 | 26.00–64.00 | 17.00–75.00 | |
Parity | 0.261 | |||
0 | 28 (25.7%) | 16 (28.6%) | 12 (22.6%) | |
1 | 16 (14.7%) | 6 (10.7%) | 10 (18.9%) | |
2 | 23 (21.1%) | 15 (26.8%) | 8 (15.1%) | |
> 3 | 42 (38.5%) | 19 (33.9%) | 23 (43.4%) | |
IMT | 0.353 | |||
Mean ± Std | 21.30 ± 3.907 | 20.96 ± 3.675 | 21.66 ± 4.143 | |
Median | 21.30 | 21.25 | 21.40 | |
Ascites | 0.089 | |||
Mean ± Std | 1652.56 ± 3664.119 | 1703.75 ± 3393.296 | 1598.49 ± 3962.289 | |
Median | 300.00 | 400.00 | 300.00 | |
Stage | 0.0001 | |||
II | 42 (38.5%) | 8 (14.3%) | 34 (64.2%) | |
III | 57 (52.3%) | 38 (67.9%) | 19 (35.8%) | |
IV | 10 (9.2%) | 10 (17.9%) | 0 (0.0%) | |
Histopathology | 0.559 | |||
Serous | 27 (24.8%) | 18 (32.1%) | 9 (17.0%) | |
Mucinous | 38 (34.9%) | 12 (21.4%) | 26 (49.1%) | |
Endometrioid | 21 (19.3%) | 14 (25.0%) | 7 (13.2%) | |
Clear cell | 16 (14.7%) | 8 (14.3%) | 8 (15.1%) | |
Others | 7 (6.4%) | 4 (7.1%) | 3 (5.7%) | |